Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

746
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
746
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

623
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
623
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To the Editor: Severe Necrotizing Lung Infections: Definitions and Therapeutic Indications.

Journal of intensive care medicine·2026
Same author

Synergistic activity of dual β-lactams against <i>Mycobacterium avium</i> complex.

Microbiology spectrum·2026
Same author

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant <i>Mycobacterium tuberculosis</i>.

mBio·2025
Same author

Severe Tuberculosis.

The Medical clinics of North America·2025
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Drug-Resistant Tuberculosis: Challenges and Progress.

Sebastian G Kurz1, Jennifer J Furin2, Charles M Bark3

  • 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Tufts University School of Medicine, 800 Washington Street, #257, Boston, MA 02111, USA.

Infectious Disease Clinics of North America
|May 22, 2016
PubMed
Summary
This summary is machine-generated.

Antimicrobial resistance in tuberculosis (TB) arises from mutations. Effective combination drug therapy under supervision can prevent resistant strains, but global challenges hinder this. Advances in diagnostics and drugs offer new hope for TB control.

Keywords:
Antimicrobial resistanceDrug-resistant tuberculosisMycobacterium tuberculosis

More Related Videos

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Evolutionary Biology

Background:

  • Antimicrobial resistance (AMR) is an evolutionary process driven by spontaneous mutations.
  • Mycobacterium tuberculosis develops resistance through chromosomal mutations.
  • Factors like limited resources and poverty contribute to the global rise of drug-resistant tuberculosis.

Purpose of the Study:

  • To highlight the mechanisms of antimicrobial resistance in Mycobacterium tuberculosis.
  • To underscore the importance of well-designed combination drug regimens and supervised therapy.
  • To discuss the global response and advancements in combating drug-resistant TB.

Main Methods:

  • Review of evolutionary processes in antimicrobial resistance.
  • Analysis of mutation-based resistance in Mycobacterium tuberculosis.
  • Assessment of factors contributing to the emergence of drug-resistant strains.
  • Evaluation of international community's response and scientific advancements.

Main Results:

  • Spontaneous chromosomal mutations are the basis for resistance in Mycobacterium tuberculosis.
  • Supervised combination drug therapy is crucial for preventing drug-resistant strains.
  • Global challenges have led to widespread drug-resistant tuberculosis.
  • Significant progress has been made in diagnostics, drug development, and understanding resistance mechanisms.

Conclusions:

  • Effective TB control requires robust combination drug regimens and supervised treatment.
  • Continued international support is vital for developing new tools and strategies against drug-resistant TB.
  • Advancements in diagnostics, therapeutics, and understanding resistance mechanisms are improving TB control efforts.